tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB
US Market
Advertisement

Biogen (BIIB) Technical Analysis

Compare
4,969 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is 7.86, suggesting Biogen is a Sell.
Biogen’s (BIIB) 20-Day exponential moving average is 165.82, while Biogen’s (BIIB) share price is $181.94, making it a Buy.
Biogen’s (BIIB) 50-Day exponential moving average is 155.72, while Biogen’s (BIIB) share price is $181.94, making it a Buy.

Biogen (BIIB) Pivot Points

Nov 27, 2025, 03:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
170.83
173.46
177.71
180.34
184.59
187.22
191.47
Fibonacci
173.46
176.09
177.71
180.34
182.97
184.59
187.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Nov 27, 2025, 03:35 PM
Period
Simple
Exponential
MA5
176.84Buy
177.54Buy
MA10
171.79Buy
172.53Buy
MA20
163.28Buy
165.82Buy
MA50
153.02Buy
155.72Buy
MA100
143.85Buy
148.16Buy
MA200
137.13Buy
143.28Buy
Biogen’s (BIIB) 10-Day exponential moving average is 172.53, while Biogen’s (BIIB) share price is $181.94, making it a Buy.
Biogen’s (BIIB) 100-Day exponential moving average is 148.16, while Biogen’s (BIIB) share price is $181.94, making it a Buy.
Biogen’s (BIIB) stock price is $181.94 and Biogen’s (BIIB) 50-day simple moving average is 153.02, creating a Buy signal.
Biogen’s (BIIB) stock price is $181.94 and Biogen’s (BIIB) 100-day simple moving average is 143.85, creating a Buy signal.
Biogen’s (BIIB) stock price is $181.94 and Biogen’s (BIIB) 200-day simple moving average is 137.13, creating a Buy signal.

Biogen (BIIB) Technical Indicators

Nov 27, 2025, 03:35 PM
Name
Value
Implied Action
RSI (14)
79.89
Sell
STOCH (9,6)
80.42
Sell
STOCHRSI (14)
85.97
Sell
MACD (12,26)
7.86
Sell
ADX (14)
34.76
Neutral
Williams %R
-9.69
Sell
CCI (14)
148.26
Sell
ATR (14)
5.51
-
Ultimate Oscillator
61.91
Neutral
ROC
16.08
Buy
Biogen’s (BIIB) Relative Strength Index (RSI) is 79.89, creating a Sell signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 34.76, creating a Neutral signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is 148.26, creating a Sell signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is 16.08, creating a Buy signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Buy.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 79.89, which suggests BIIB is a Sell.
      What is BIIB’s MACD?
      BIIB’s MACD is 7.86, which suggests BIIB is a Sell.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 176.84, which suggests BIIB is a Buy.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 163.28, which suggests BIIB is a Buy.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 153.02, which suggests BIIB is a Buy.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 137.13, which suggests BIIB is a Buy.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -9.69, which suggests BIIB is a Sell.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is 148.26, which suggests BIIB is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis